牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

特宝生物（688278）

4.4

综合诊断：4.4分打败了10%的股票！

卖出
减持
中性
增持
买入

短期趋势：
短期行情可能回暖，可适量买进股票，作短线反弹行情。
中期趋势：
有加速下跌的趋势。
长期趋势：
已有376家主力机构披露2025-12-31报告期持股数据，持仓量总计1.18亿股，占流通A股28.94%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

3.0分

3.3分

5.9分

1.6分

7.1分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：3.0技术面打败了1%的股票技术面评分前10的股票

近期的平均成本为56.20元。空头行情中，并且有加速下跌的趋势。

技术面得分最高的股票

平均成本

近期的平均成本为56.20元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"56.20","date":1778057704,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。

[{"date":"2026.05.07","stock":"0.60","trade":"0.68","ind":"0.48"},{"date":"2026.05.06","stock":"-3.11","trade":"-0.25","ind":"1.17"},{"date":"2026.04.30","stock":"-1.85","trade":"-0.48","ind":"0.11"},{"date":"2026.04.29","stock":"0.85","trade":"-0.20","ind":"0.71"},{"date":"2026.04.28","stock":"1.47","trade":"-0.90","ind":"-0.19"},{"date":"2026.04.27","stock":"-0.85","trade":"-0.12","ind":"0.16"},{"date":"2026.04.24","stock":"-4.33","trade":"-1.02","ind":"-0.33"},{"date":"2026.04.23","stock":"-2.98","trade":"-2.31","ind":"-0.32"},{"date":"2026.04.22","stock":"-0.21","trade":"1.01","ind":"0.52"},{"date":"2026.04.21","stock":"-0.99","trade":"-1.07","ind":"0.07"},{"date":"2026.04.20","stock":"-1.25","trade":"-0.70","ind":"0.76"},{"date":"2026.04.17","stock":"-0.62","trade":"-1.25","ind":"-0.10"},{"date":"2026.04.16","stock":"0.02","trade":"0.56","ind":"0.70"},{"date":"2026.04.15","stock":"2.67","trade":"1.39","ind":"0.01"},{"date":"2026.04.14","stock":"-0.31","trade":"1.04","ind":"0.95"},{"date":"2026.04.13","stock":"-1.67","trade":"0.23","ind":"0.06"},{"date":"2026.04.10","stock":"0.22","trade":"1.34","ind":"0.51"},{"date":"2026.04.09","stock":"-0.49","trade":"-1.48","ind":"-0.72"},{"date":"2026.04.08","stock":"1.79","trade":"1.96","ind":"2.70"},{"date":"2026.04.07","stock":"-0.59","trade":"0.21","ind":"0.26"},{"date":"2026.04.03","stock":"-3.61","trade":"-2.48","ind":"-1.00"}]

特宝生物,上证指数,生物制品指数

压力支撑

该股压力位为56.16元，支撑位为55.58元。

[{"text":"\u538b\u529b\u4f4d","value":"56.16","date":1778083200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"55.58","date":1778083200,"color":"0x0b52a1"}]

多空趋势

空头行情中，并且有加速下跌的趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.3资金面打败了41%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：05月07日 20:32

机构今日流向(万元)	-1077.21	机构5日流向(万元)	-5141.99
机构10日流向(万元)	-11921.25	机构20日流向(万元)	-17278.17

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加693.78万股，其中基金净减仓40家，主力净增仓48家，请投资者中长期谨慎为宜。

截止2025-12-31，共376家主力机构（基金374家，一般法人1家，信托公司1家），持仓量总计11812.72万股，占流通A股28.94%
其中，基金持仓与2025-06-30相比：
增仓：74家，增持 496.28万股
减仓：114家，减持 620.98万股
新出现在主力名单中：173家，持有3480万股
从主力名单中消失：125家，原持有342.76万股

消息面诊股

诊断结果：5.9消息面打败了51%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2026-04-17
利好	分红转增	10派6.2元(含税)	2026-03-27
一般消息	募资投向		2026-03-27
一般消息	高管变动	取消监事会	2025-12-18
一般消息	高管变动	委员会更名	2025-12-02
一般消息	分红转增	不分配不转增	2025-08-21
一般消息	资产重组	公司股权转让	2025-07-04

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：1.6行业面打败了15%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2026.05.07","price":"0.48","value":"0.68"},{"date":"2026.05.06","price":"1.17","value":"-0.25"},{"date":"2026.04.30","price":"0.11","value":"-0.48"},{"date":"2026.04.29","price":"0.71","value":"-0.20"},{"date":"2026.04.28","price":"-0.19","value":"-0.90"},{"date":"2026.04.27","price":"0.16","value":"-0.12"},{"date":"2026.04.24","price":"-0.33","value":"-1.02"},{"date":"2026.04.23","price":"-0.32","value":"-2.31"},{"date":"2026.04.22","price":"0.52","value":"1.01"},{"date":"2026.04.21","price":"0.07","value":"-1.07"},{"date":"2026.04.20","price":"0.76","value":"-0.70"},{"date":"2026.04.17","price":"-0.10","value":"-1.25"},{"date":"2026.04.16","price":"0.70","value":"0.56"},{"date":"2026.04.15","price":"0.01","value":"1.39"},{"date":"2026.04.14","price":"0.95","value":"1.04"},{"date":"2026.04.13","price":"0.06","value":"0.23"},{"date":"2026.04.10","price":"0.51","value":"1.34"},{"date":"2026.04.09","price":"-0.72","value":"-1.48"},{"date":"2026.04.08","price":"2.70","value":"1.96"},{"date":"2026.04.07","price":"0.26","value":"0.21"},{"date":"2026.04.03","price":"-1.00","value":"-2.48"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	赛伦生物	29.31%	2.65%	5.0分
2	昊帆生物	21.10%	-1.77%	6.1分
3	近岸蛋白	19.30%	3.30%	4.7分
4	*ST双成	18.75%	3.75%	6.5分
5	欧林生物	18.32%	21.53%	6.1分
6	万泽股份	15.39%	3.98%	6.0分
7	智翔金泰	11.51%	-3.98%	4.3分
8	金迪克	8.55%	3.43%	5.0分
9	*ST四环	8.24%	3.07%	5.3分
10	辽宁成大	6.96%	4.45%	5.8分
11	沃森生物	6.48%	10.04%	5.7分
12	优宁维	6.06%	2.49%	6.2分
13	康华生物	5.30%	2.90%	5.3分
14	东宝生物	4.55%	0.18%	5.6分
15	君实生物	4.41%	-0.66%	5.1分
16	诺唯赞	4.29%	3.70%	5.4分
17	百克生物	4.12%	0.28%	5.0分
18	康泰生物	3.33%	1.49%	4.8分
19	长春高新	3.25%	2.73%	5.1分
20	神州细胞	2.88%	3.35%	4.6分
21	-	0.59%	-1.81%	分
22	智飞生物	0.33%	3.01%	5.3分
23	华兰疫苗	-0.41%	0.98%	6.0分
24	西藏药业	-0.48%	3.49%	5.3分
25	义翘神州	-1.20%	-1.72%	5.4分
26	华兰生物	-1.30%	-0.28%	4.9分
27	百普赛斯	-1.38%	-2.77%	5.4分
28	我武生物	-1.76%	-4.35%	4.7分
29	-	-1.77%	7.99%	分
30	上海莱士	-3.64%	1.65%	5.5分
31	成大生物	-4.18%	-1.18%	4.5分
32	赛升药业	-4.43%	-6.42%	4.1分
33	天坛生物	-4.65%	-2.35%	4.8分
34	博晖创新	-4.83%	-0.72%	5.1分
35	甘李药业	-5.02%	0.02%	4.5分
36	艾迪药业	-5.26%	-1.13%	4.9分
37	卫光生物	-5.32%	-1.89%	5.4分
38	博雅生物	-6.61%	-3.18%	4.6分
39	迈威生物	-6.76%	-3.92%	4.2分
40	康辰药业	-7.02%	-1.93%	5.1分
41	通化东宝	-7.07%	-7.82%	4.6分
42	诺诚健华	-8.03%	-3.19%	5.2分
43	康希诺	-8.07%	-6.47%	3.8分
44	派林生物	-8.46%	-4.26%	4.8分
45	百奥泰	-9.57%	-9.09%	4.7分
46	安科生物	-10.03%	-1.01%	4.8分
47	特宝生物	-11.28%	-2.10%	4.4分
48	荣昌生物	-12.81%	-3.74%	5.0分
49	禾元生物	-14.00%	-7.68%	4.5分
50	康弘药业	-14.14%	-2.81%	4.9分
51	*ST未名	-16.46%	-15.77%	4.3分
52	科兴制药	-19.94%	-11.26%	4.3分
53	三生国健	-20.04%	-3.21%	5.0分
54	-	-46.10%	-35.49%	分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：7.1基本面打败了90%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：中（95分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：很强，居行业前列，两项指标的行业排名分别为 4/70 ， 8/70。

[{"date":"2026-03-31","value":"4.65","vol":"-2.96"},{"date":"2025-12-31","value":"34.36","vol":"-8.40"},{"date":"2025-09-30","value":"23.95","vol":"-10.09"},{"date":"2025-06-30","value":"16.12","vol":"-0.67"},{"date":"2025-03-31","value":"6.87","vol":"0.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	4.65	34.36	23.95	16.12	6.87
行业(%)	-2.96	-8.40	-10.09	-0.67	0.44

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"89.45","vol":"61.64"},{"date":"2025-12-31","value":"92.96","vol":"66.98"},{"date":"2025-09-30","value":"92.56","vol":"67.71"},{"date":"2025-06-30","value":"92.98","vol":"67.98"},{"date":"2025-03-31","value":"93.17","vol":"69.02"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	89.45	92.96	92.56	92.98	93.17
行业(%)	61.64	66.98	67.71	67.98	69.02

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，两项指标的行业排名分别为 18/70 ， 26/70。

[{"date":"2026-03-31","value":"18.48","vol":"16.15"},{"date":"2025-12-31","value":"31.18","vol":"35.93"},{"date":"2025-09-30","value":"26.85","vol":"45.81"},{"date":"2025-06-30","value":"26.96","vol":"7037.48"},{"date":"2025-03-31","value":"23.48","vol":"6245.21"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	18.48	31.18	26.85	26.96	23.48
行业(%)	16.15	35.93	45.81	7037.48	6245.21

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-9.68","vol":"74.78"},{"date":"2025-12-31","value":"24.61","vol":"34.78"},{"date":"2025-09-30","value":"20.21","vol":"45.67"},{"date":"2025-06-30","value":"40.60","vol":"5.32"},{"date":"2025-03-31","value":"41.40","vol":"-8.96"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-9.68	24.61	20.21	40.60	41.40
行业(%)	74.78	34.78	45.67	5.32	-8.96

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，两项指标的行业排名分别为 1/70 ， 27/70。

[{"date":"2026-03-31","value":"0.18","vol":"0.06"},{"date":"2025-12-31","value":"1.00","vol":"0.30"},{"date":"2025-09-30","value":"0.73","vol":"0.21"},{"date":"2025-06-30","value":"0.48","vol":"0.14"},{"date":"2025-03-31","value":"0.22","vol":"0.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.18	1.00	0.73	0.48	0.22
行业(次)	0.06	0.30	0.21	0.14	0.06

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.20","vol":"0.29"},{"date":"2025-12-31","value":"0.77","vol":"1.30"},{"date":"2025-09-30","value":"0.58","vol":"0.90"},{"date":"2025-06-30","value":"0.36","vol":"0.56"},{"date":"2025-03-31","value":"0.17","vol":"0.26"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.20	0.77	0.58	0.36	0.17
行业(次)	0.29	1.30	0.90	0.56	0.26

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"16.84","vol":"-71.66"},{"date":"2025-12-31","value":"21.24","vol":"12.85"},{"date":"2025-09-30","value":"11.41","vol":"0.21"},{"date":"2025-06-30","value":"18.37","vol":"-1404.66"},{"date":"2025-03-31","value":"30.70","vol":"-47.97"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	16.84	21.24	11.41	18.37	30.70
行业	-71.66	12.85	0.21	-1404.66	-47.97

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.75","vol":"1.77"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.86","vol":"1.58"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	1.75	-	1.86	-
行业	0.00	1.77	0.00	1.58	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 32/70 ， 33/70。

[{"date":"2026-03-31","value":"4.79","vol":"6.75"},{"date":"2025-12-31","value":"3.86","vol":"5.88"},{"date":"2025-09-30","value":"3.84","vol":"6.07"},{"date":"2025-06-30","value":"5.20","vol":"6.70"},{"date":"2025-03-31","value":"5.56","vol":"7.82"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	4.79	3.86	3.84	5.20	5.56
行业	6.75	5.88	6.07	6.70	7.82

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"3.92","vol":"5.22"},{"date":"2025-12-31","value":"3.23","vol":"4.49"},{"date":"2025-09-30","value":"3.04","vol":"4.89"},{"date":"2025-06-30","value":"4.06","vol":"5.34"},{"date":"2025-03-31","value":"4.47","vol":"6.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	3.92	3.23	3.04	4.06	4.47
行业	5.22	4.49	4.89	5.34	6.40

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 24/70 ， 28/70。

[{"date":"2026-03-31","value":"18.66","vol":"27.44"},{"date":"2025-12-31","value":"21.13","vol":"27.58"},{"date":"2025-09-30","value":"20.52","vol":"28.02"},{"date":"2025-06-30","value":"14.15","vol":"26.70"},{"date":"2025-03-31","value":"13.52","vol":"26.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	18.66	21.13	20.52	14.15	13.52
行业(%)	27.44	27.58	28.02	26.70	26.06

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.23","vol":"1.46"},{"date":"2025-12-31","value":"0.27","vol":"1.28"},{"date":"2025-09-30","value":"0.26","vol":"0.58"},{"date":"2025-06-30","value":"0.16","vol":"1.13"},{"date":"2025-03-31","value":"0.16","vol":"0.79"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.23	0.27	0.26	0.16	0.16
行业(%)	1.46	1.28	0.58	1.13	0.79

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
国投证券	2026-04-22	买入
国泰海通证券	2026-04-17	买入	买入
兴业证券	2026-04-15	增持
西部证券	2026-04-13	买入
国信证券	2026-04-01	买入
中信建投证券	2026-04-01	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"2.87","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.55","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"8.28","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"10.31","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"13.16","blueLineValue":"3.23","type":"YC"}]

[特宝生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]